Savannah C Partridge1, Karen M Stone2, Roberta M Strigel3, Wendy B DeMartini3, Sue Peacock4, Constance D Lehman4. 1. Department of Radiology- University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-200, Seattle, WA 98109-1023. Electronic address: scp3@u.washington.edu. 2. Department of Radiology- University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-200, Seattle, WA 98109-1023; Breast Imaging, Radia, Everett, Washington. 3. Department of Radiology- University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-200, Seattle, WA 98109-1023; Department of Radiology, University of Wisconsin, Madison, Wisconsin. 4. Department of Radiology- University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-200, Seattle, WA 98109-1023.
Abstract
RATIONALE AND OBJECTIVES: Breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) scanning protocols vary widely. The purpose of this study was to determine the effects of postcontrast timing on delayed-phase lesion kinetics assessment and ability to discriminate malignant from benign lesions. MATERIALS AND METHODS: Following institutional review board approval, we retrospectively reviewed all lesions assessed on magnetic resonance examinations from April 2005 to June 2006. DCE-MRI was performed with 90-second temporal resolution. Delayed-phase kinetic parameters including percentages of persistent, plateau, and washout, and categorizations of predominant and worst curve type were compared between 4.5 and 7.5 minutes postcontrast. Ability to discriminate benign and malignant lesions based on delayed-phase kinetic parameters was compared between postcontrast timings by receiver operating characteristic (ROC) analysis. RESULTS: Two hundred eighty consecutive breast lesions (206 malignant and 74 benign) were evaluated in 228 women. Comparing kinetics assessments at 7.5 versus 4.5 minutes: volume percentage of washout increased in malignancies by a mean of 9.4% (P<.0001) and increased slightly in benign lesions (mean 3.2%, P=.007); predominant curve type categorizations changed significantly only for malignancies (P<.0001); and worst curve categorizations did not change significantly for either benign or malignant lesions (P>.05). There were no significant differences between timings in area under ROC curves for delayed-phase kinetic parameters. CONCLUSIONS: The choice of delayed postcontrast timing more strongly affects the kinetics assessments for malignancies than benign breast lesions, but our results suggest that a shortened breast DCE-MRI protocol may not significantly impact diagnostic accuracy. Furthermore, worst curve type classifications are least affected by postcontrast timing and may provide reliable assessment of delayed-phase kinetics across protocols.
RATIONALE AND OBJECTIVES: Breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) scanning protocols vary widely. The purpose of this study was to determine the effects of postcontrast timing on delayed-phase lesion kinetics assessment and ability to discriminate malignant from benign lesions. MATERIALS AND METHODS: Following institutional review board approval, we retrospectively reviewed all lesions assessed on magnetic resonance examinations from April 2005 to June 2006. DCE-MRI was performed with 90-second temporal resolution. Delayed-phase kinetic parameters including percentages of persistent, plateau, and washout, and categorizations of predominant and worst curve type were compared between 4.5 and 7.5 minutes postcontrast. Ability to discriminate benign and malignant lesions based on delayed-phase kinetic parameters was compared between postcontrast timings by receiver operating characteristic (ROC) analysis. RESULTS: Two hundred eighty consecutive breast lesions (206 malignant and 74 benign) were evaluated in 228 women. Comparing kinetics assessments at 7.5 versus 4.5 minutes: volume percentage of washout increased in malignancies by a mean of 9.4% (P<.0001) and increased slightly in benign lesions (mean 3.2%, P=.007); predominant curve type categorizations changed significantly only for malignancies (P<.0001); and worst curve categorizations did not change significantly for either benign or malignant lesions (P>.05). There were no significant differences between timings in area under ROC curves for delayed-phase kinetic parameters. CONCLUSIONS: The choice of delayed postcontrast timing more strongly affects the kinetics assessments for malignancies than benign breast lesions, but our results suggest that a shortened breast DCE-MRI protocol may not significantly impact diagnostic accuracy. Furthermore, worst curve type classifications are least affected by postcontrast timing and may provide reliable assessment of delayed-phase kinetics across protocols.
Authors: Mitchell D Schnall; Jeffrey Blume; David A Bluemke; Gia A DeAngelis; Nanette DeBruhl; Steven Harms; Sylvia H Heywang-Köbrunner; Nola Hylton; Christiane K Kuhl; Etta D Pisano; Petrina Causer; Stuart J Schnitt; David Thickman; Carol B Stelling; Paul T Weatherall; Constance Lehman; Constantine A Gatsonis Journal: Radiology Date: 2006-01 Impact factor: 11.105
Authors: Teresa C Williams; Wendy B DeMartini; Savannah C Partridge; Sue Peacock; Constance D Lehman Journal: Radiology Date: 2007-05-16 Impact factor: 11.105
Authors: Debbie Saslow; Carla Boetes; Wylie Burke; Steven Harms; Martin O Leach; Constance D Lehman; Elizabeth Morris; Etta Pisano; Mitchell Schnall; Stephen Sener; Robert A Smith; Ellen Warner; Martin Yaffe; Kimberly S Andrews; Christy A Russell Journal: CA Cancer J Clin Date: 2007 Mar-Apr Impact factor: 508.702
Authors: Robert L Gutierrez; Roberta M Strigel; Savannah C Partridge; Wendy B DeMartini; Peter R Eby; Karen M Stone; Sue Peacock; Constance D Lehman Journal: AJR Am J Roentgenol Date: 2012-09 Impact factor: 3.959
Authors: Chengyue Wu; Federico Pineda; David A Hormuth; Gregory S Karczmar; Thomas E Yankeelov Journal: Magn Reson Med Date: 2018-10-28 Impact factor: 4.668
Authors: Daly Avendano; Maria Adele Marino; Doris Leithner; Sunitha Thakur; Blanca Bernard-Davila; Danny F Martinez; Thomas H Helbich; Elizabeth A Morris; Maxine S Jochelson; Pascal A T Baltzer; Paola Clauser; Panagiotis Kapetas; Katja Pinker Journal: Breast Cancer Res Date: 2019-12-04 Impact factor: 6.466
Authors: Amita Shukla-Dave; Nancy A Obuchowski; Thomas L Chenevert; Sachin Jambawalikar; Lawrence H Schwartz; Dariya Malyarenko; Wei Huang; Susan M Noworolski; Robert J Young; Mark S Shiroishi; Harrison Kim; Catherine Coolens; Hendrik Laue; Caroline Chung; Mark Rosen; Michael Boss; Edward F Jackson Journal: J Magn Reson Imaging Date: 2018-11-19 Impact factor: 5.119